The circadian pacemaker within the suprachiasmatic nucleus (SCN) confers daily rhythms to bodily functions. In nature, the circadian clock will adopt a 24-h period by synchronizing to the solar light/dark cycle. This light entrainment process is mediated, in part, at glutamatergic synapses formed between retinal ganglion afferents and SCN neurons. N-methyl-D-aspartate receptors (NMDARs) located on SCN neurons gate light-induced phase resetting. Despite their importance in circadian physiology, little is known about their functional stoichiometry. We investigated the NR2-subunit composition with whole cell recordings of SCN neurons within the murine hypothalamic brain slice using a combination of subtype-selective NMDAR antagonists and voltage-clamp protocols. We found that extracellular magnesium ([Mg]o) strongly blocks SCN NMDARs exhibiting affinities and voltage sensitivities associated with NR2A and NR2B subunits. These NMDAR currents were inhibited strongly by NR2B-selective antagonists, Ro 25-6981 (3.5 μM, 55.0 ± 9.0% block; mean ± SE) and ifenprodil (10 μM, 55.8 ± 3.0% block). The current remaining showed decreased [Mg]o affinities reminiscent of NR2C and NR2D subunits but was highly sensitive to [Zn]o, a potent NR2A blocker, showing a ∼44.2 ± 1.1% maximal inhibition at saturating concentrations with an IC50 of 7.8 ± 1.1 nM. Considering the selectivity, efficacy, and potency of the drugs used in combination with [Mg]o-block characteristics of the NMDAR, our data show that both diheteromeric NR2B NMDARs and triheteromeric NR2A NMDARs (paired with an NR2C or NR2D subunits) account for the vast majority of the NMDAR current within the SCN.